Most recently, Allyx Therapeutics raised $26.4M in its Early Stage VC (May 2026).
- ·Watch Allyx Therapeutics: the Monday email on marks, rounds and moves
Allyx Therapeutics round by round
4 roundsHow much has Allyx Therapeutics raised?
Allyx Therapeutics has raised $13.2 million across 4 recorded rounds since 2021. The largest was a $7.6 million early-stage round in May 2021; the most recent was a $26.4 million early-stage round in May 2026.
Allyx Therapeutics has filed 2 Form Ds with the SEC since 2021, most recently in Feb 2023 ($2.3 million sold to 11 investors).
Allyx Therapeutics investors
10 investors are on record for Allyx Therapeutics, including National Institutes of Health, Connecticut Innovations, Bristol-Myers Squibb and Spring Mountain Capital. The early-stage round in May 2026 drew 32 investors.
10 investors have backed Allyx Therapeutics.
Frequently asked about Allyx Therapeutics
- How much has Allyx Therapeutics raised?
- Allyx Therapeutics has raised $13.2M in total across 4 recorded funding rounds.
- When was Allyx Therapeutics's last funding round?
- Allyx Therapeutics's most recent recorded round was Early Stage VC in May 2026, raising $26.4M.